Business

Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab

Mar 29, 2026 - 23:00
 0
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
Read More

Related Posts

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  10

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  1

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025  3

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025  1

Elon Musk says DOGE cuts necessary, but face headwinds according to Fox poll

Elon Musk says DOGE cuts necessary, but face headwinds ...

Mar 21, 2025  2

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  9